NCT03961360View on ClinicalTrials.gov

Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

May 6, 2019

Primary Completion Date

April 10, 2023

Study Completion Date

April 10, 2023

Conditions
Pre-EclampsiaHypertension in PregnancyObesity
Interventions
DRUG

Aspirin 81 mg

Low dose aspirin was initially reported as having a beneficial effect at preeclampsia

DRUG

Aspirin 162 mg

Low dose aspirin was initially reported as having a beneficial effect at preeclampsia

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT03961360 - Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida | Biotech Hunter | Biotech Hunter